Biolevox(TM) HA intraarticular injections

Biolevox(TM) HA intraarticular injections

Products
Biolevox(TM) HA intraarticular injections
Biolevox(TM) HA intraarticular injections

Information

Biolevox(TM) HA is a line hyaluronic acid gels for an intraarticular injections in pre-filled syringes. Sodium hyaluronate obtained by bacterial fermentation is used as a viscoelastic gel in osteoarthritic joint. Hyaluronic acid role in joint is to facilitate the joint movement, relief pain, protect intra-articular cartilage and stimulate the production of endogenous hyaluronric acid. Biolevox(TM) HA is a line has the high content of hyaluronic acid in a single multi application doses.
Main Categories
BiopharmaceuticalsFinished Dosage FormsPharmaceutical Packaging
All Categories
BiopharmaceuticalsFinished Dosage FormsInjectablesMedical Devices and Medical PackagingPharmaceutical PackagingRegenerative Medicine
Distribution areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
Poland
BiovicoBiovico is a biotechnology and pharmaceutical company focused on researching and developing new innovative and rigorously tested products, manufacturing in the highest GMP level quality and providing with comprehensive and holistic solutions to professionals and patients around the world. From inception in 2008 R&D was a clear focus, understanding that the most important and lasting effects can come only through scientific endeavour. Very soon the first HA product Biolevox family was developed and the line continued to grow and expand in terms of indications for use and viability, obtaining a very significant share of the Polish orthopedic market. Further products related to autologous blood derived platelet rich plasma - Xerthra family and multiple others. It has led to progress and development in multiple fields with pharmaceutical, medical devices and biofermentation. 15 years on the market, nearly 50 countries all around the world, over 200 employees, Biovico has finished several clinical studies for unique products and started many others. With Multiple patents to its name, company's fields of expansion and increasing revenues are the staple of good business. Expanding both in terms of reach to new markets and in man-power at R&D, creating new exciting departments offering services including contract manufacturing, increasing production capacity by 500%, creating a logistics center and both organic and non-organic growth in M&A processes. Unique products include Lipotris, Wint, Monoshot, Hyrac, Progum - provide most exciting new solutions.

Log in

See all the content and easy-to-use features by logging in or registering!